← All Congress trades

Novartis Ag (NVS) — Congressional Trades

22 U.S. lawmakers have disclosed 67 Novartis Ag trades under the STOCK Act — 43 buys and 24 sells between 2015 and 2026. Congress has been net buyers of NVS, and their disclosed buys are up 20.8% versus the latest close.

67Trades
43Buys
24Sells
22Members
$151.72Latest close 2026-08-13
+20.8%Congress buys vs latest close*

*Notional-weighted price return on lawmakers' disclosed buys of NVS, marked to the latest close — per-share (share counts aren't disclosed).

64% buys36% sells

Which party is trading NVS?

Democrats
16 buys · 16 sells
10 members · 32 trades
Republicans
22 buys · 4 sells
9 members · 26 trades
Independents
0 buys · 1 sells
1 member · 1 trade

Who profited most from NVS?

Lawmakers ranked by notional-weighted return on their disclosed NVS buys (last ~3y), marked to the latest close.

1 Sheldon Whitehouse
+46.5%
2 Lisa McClain
+18.8%
3 Alan Armstrong
+0.6%
DateMemberTypeAmountEst. priceLatest closeReturn
2026-03-31Alan ArmstrongBUY$1K–$15K$152.75$151.72 2026-08-13-0.7%
2026-03-30Alan ArmstrongBUY$15K–$50K$150.36$151.72 2026-08-13+0.9%
2025-09-25Lisa McClainSELL$1K–$15K$122.23$151.72 2026-08-13-4.3% rt
2025-09-11Lisa McClainBUY$1K–$15K$127.70$151.72 2026-08-13+18.8%
2025-03-24George WhitesidesSELL$100K–$250K$111.09$151.72 2026-08-13-36.6% exit
2024-04-09Sheldon WhitehouseSELL$1K–$15K$95.81$151.72 2026-08-13-7.5% rt
2023-09-20Sheldon WhitehouseBUY$15K–$50K$103.58$151.72 2026-08-13+46.5%
2023-04-26Thomas R CarperBUY$1K–$15K$102.54$151.72 2026-08-13+48.0%
2022-01-27Donald Sternoff Beyer Jr.BUY$1K–$15K$85.14$151.72 2026-08-13+78.2%
2021-12-22Donald Sternoff Beyer Jr.SELL$1K–$15K$86.31$151.72 2026-08-13-75.8% exit
2021-12-15Shelley M CapitoSELL$1K–$15K$81.52$151.72 2026-08-13+8.6% rt
2021-09-17Donald Sternoff Honorable Beyer JrSELL$1K–$15K$83.48$151.72 2026-08-13-81.7% exit
2020-12-09David P. RoeBUY$1K–$15K$91.61$151.72 2026-08-13+65.6%
2020-11-23Alan S. LowenthalSELL$15K–$50K$87.31$151.72 2026-08-13+7.0% rt
2020-11-23Alan S. LowenthalSELL$1K–$15K$87.31$151.72 2026-08-13+7.0% rt
2020-11-23Alan S. LowenthalSELL$1K–$15K$87.31$151.72 2026-08-13+7.0% rt
2020-10-05Donald Sternoff Beyer JrSELL$1K–$15K$88.27$151.72 2026-08-13-71.9% exit
2020-05-06David P. RoeBUY$1K–$15K$85.35$151.72 2026-08-13+77.8%
2019-07-15Mike KellyBUY$1K–$15K$89.27$151.72 2026-08-13+70.0%
2019-06-17DIANNE FEINSTEINSELL$1K–$15K$89.76$151.72 2026-08-13-69.0% exit
2019-04-18John RutherfordBUY$1K–$15K$76.41$151.72 2026-08-13+98.6%
2019-04-05William CassidySELL$1K–$15K$84.22$151.72 2026-08-13+9.3% rt
2019-04-05William CassidySELL$1K–$15K$84.22$151.72 2026-08-13+29.8% rt
2019-02-15Alan S. LowenthalBUY$268.98–$268.98$80.54$151.72 2026-08-13+88.4%
2019-02-15Alan S. LowenthalBUY$1K–$15K$80.54$151.72 2026-08-13+88.4%
2019-02-15Alan S. LowenthalBUY$896.59–$896.59$80.54$151.72 2026-08-13+88.4%
2019-01-25William CassidyBUY$1K–$15K$77.02$151.72 2026-08-13+97.0%
2018-12-07William CassidySELL$1K–$15K$78.03$151.72 2026-08-13+20.2% rt
2018-11-30Alan S. LowenthalBUY$909.75–$909.75$82.02$151.72 2026-08-13+85.0%
2018-11-30Alan S. LowenthalBUY$1K–$15K$82.02$151.72 2026-08-13+85.0%
2018-11-30Alan S. LowenthalBUY$363.9–$363.9$82.02$151.72 2026-08-13+85.0%
2018-11-30Alan S. LowenthalBUY$1K–$15K$82.02$151.72 2026-08-13+85.0%
2018-11-29Alan S. LowenthalBUY$1K–$15K$81.59$151.72 2026-08-13+86.0%
2018-11-29Alan S. LowenthalBUY$816.61–$816.61$81.59$151.72 2026-08-13+86.0%
2018-11-29Alan S. LowenthalBUY$15K–$50K$81.59$151.72 2026-08-13+86.0%
2018-11-21James B. RenacciSELL$1K–$15K$79.78$151.72 2026-08-13-15.9% rt
2018-11-16DIANNE FEINSTEINSELL$1K–$15K$78.63$151.72 2026-08-13-93.0% exit
2018-09-19James B. RenacciBUY$1K–$15K$76.08$151.72 2026-08-13+99.4%
2018-04-24Shelley M CapitoBUY$1K–$15K$68.99$151.72 2026-08-13+119.9%
2018-04-24Shelley M CapitoBUY$1K–$15K$68.99$151.72 2026-08-13+119.9%
2018-04-20DIANNE FEINSTEINSELL$1K–$15K$69.78$151.72 2026-08-13-117.4% exit
2018-03-22DIANNE FEINSTEINSELL$1K–$15K$71.58$151.72 2026-08-13-112.0% exit
2018-03-21DIANNE FEINSTEINSELL$1K–$15K$72.65$151.72 2026-08-13-108.8% exit
2018-03-21DIANNE FEINSTEINSELL$1K–$15K$72.65$151.72 2026-08-13-108.8% exit
2017-12-07DIANNE FEINSTEINSELL$1K–$15K$74.27$151.72 2026-08-13-104.3% exit
2017-11-17James B. RenacciBUY$1K–$15K$75.25$151.72 2026-08-13+101.6%
2017-11-10Angus S King, Jr.SELL$1K–$15K$73.82$151.72 2026-08-13-105.5% exit
2017-09-05Shelley M CapitoBUY$1K–$15K$75.09$151.72 2026-08-13+102.0%
2017-04-21Thomas MacArthurBUY$1K–$15K$65.77$151.72 2026-08-13+130.7%
2017-03-16James B. RenacciSELL$1K–$15K$67.80$151.72 2026-08-13-27.1% rt

Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).

Next →

Frequently asked — Novartis Ag (NVS) congressional trades

Which lawmakers have traded Novartis Ag (NVS)?

22 members of the U.S. House and Senate have disclosed Novartis Ag transactions under the STOCK Act — 43 purchases and 24 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.

Which lawmakers bought NVS recently?

No member of Congress has disclosed a NVS purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.

How have Congress's NVS trades performed?

Notional-weighted, lawmakers' disclosed NVS buys are up 20.8% versus the latest close of $151.72. Each trade's own return — and realized round-trips on matched sells — is in the Return column.

Is it legal for members of Congress to trade Novartis Ag?

Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded NVS and how it performed.

Related stocks — also traded by the same lawmakers

MSFT 21AAPL 15JPM 15JNJ 15UNH 15CSCO 14CMCSA 14DIS 13SBUX 12CVS 12INTC 12QCOM 12HD 12MDT 12NEE 12PG 12AXP 12AMZN 11